Gate Bioscience: Valuation, Funding & Investors
Gate Bioscience is a biotechnology company developing molecular gates, a new class of small molecule medicines that eliminate disease-causing proteins at their source. Gate’s proprietary Molecular Gate Discovery Platform enables the rapid and repeatable discovery of selective molecular gates against high-value targets across inflammatory and neurological diseases.
Leadership & Board
- Current Number of Employees
- 41
- Current LinkedIn Followers
- 4,276
Latest Estimated Valuation
- Total Amount Raised
- $65M
- Total Funding Rounds
- 1
- Latest Funding Amount
- $65M
- Latest Funding Round
- Series B
Employee Trend
Gate Bioscience had 41 employees as of October 26, 2026. The number of employees increased by 0 (0.00%) week-over-week.
41Latest Employee Count
0(0.00%)Week-Over-Week Change
Social Trend
Gate Bioscience had 4,276 followers as of October 26, 2026. The number of followers increased by 6 (0.14%) week-over-week.
4,276Latest Followers Count
6(0.14%)Week-Over-Week Change
Funding Round
| Funding Date | Funding Round | Amount Raised | Post-Money Valuation |
|---|---|---|---|
| Nov 13, 2025 | Series B | $65.00M | ― |
Investors
| Investor Name | Funding Round |
|---|---|
| Eli Lilly and Company | Series B |
| Forbion | Series B |
| GV | Series B |
| Versant Ventures | Series B |
| ARCH Venture Partners | Series B |
| Andreessen Horowitz | Series B |
Similar Companies
A snapshot of private companies similar to Gate Bioscience, helping you discover and navigate related company profiles.
